IN2014CN03364A - - Google Patents

Download PDF

Info

Publication number
IN2014CN03364A
IN2014CN03364A IN3364CHN2014A IN2014CN03364A IN 2014CN03364 A IN2014CN03364 A IN 2014CN03364A IN 3364CHN2014 A IN3364CHN2014 A IN 3364CHN2014A IN 2014CN03364 A IN2014CN03364 A IN 2014CN03364A
Authority
IN
India
Prior art keywords
nanoparticles
cell epitopes
oligomerization domains
peptide
norovirus
Prior art date
Application number
Other languages
English (en)
Inventor
Peter Burkhard
Caroline Kulangara
Original Assignee
Alpha O Peptides Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha O Peptides Ag filed Critical Alpha O Peptides Ag
Publication of IN2014CN03364A publication Critical patent/IN2014CN03364A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/16011Caliciviridae
    • C12N2770/16023Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/16011Caliciviridae
    • C12N2770/16034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
IN3364CHN2014 2011-10-12 2012-10-05 IN2014CN03364A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11184906 2011-10-12
PCT/EP2012/069684 WO2013053642A1 (en) 2011-10-12 2012-10-05 Self-assembling peptide nanoparticles as vaccines against infection with norovirus

Publications (1)

Publication Number Publication Date
IN2014CN03364A true IN2014CN03364A (ja) 2015-09-04

Family

ID=47010584

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3364CHN2014 IN2014CN03364A (ja) 2011-10-12 2012-10-05

Country Status (9)

Country Link
US (1) US20140242104A1 (ja)
EP (1) EP2766386A1 (ja)
JP (1) JP2014530224A (ja)
CN (1) CN104136454A (ja)
AU (1) AU2012323189A1 (ja)
CA (1) CA2851917A1 (ja)
IN (1) IN2014CN03364A (ja)
RU (1) RU2014106936A (ja)
WO (1) WO2013053642A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106021974B (zh) * 2016-05-19 2019-05-03 中牧智合(北京)生物技术有限公司 对t细胞表位进行优化的方法及由此制备的肽文库的组合物
EP3600402A1 (en) * 2017-03-23 2020-02-05 Alpha-O Peptides AG Self-assembling protein nanoparticles with built-in six-helix bundle proteins
WO2019241483A1 (en) * 2018-06-13 2019-12-19 The Scripps Research Institute Nanoparticle vaccines with novel structural components
EP3964532A4 (en) * 2019-04-29 2023-06-07 Academy of Military Medical Sciences FUSION PROTEIN SELF-ASSEMBLING INTO PROTEIN NANOPARTICLES AND USE THEREOF
WO2022106860A1 (en) * 2020-11-20 2022-05-27 Pécsi Tudományegyetem Recombinant peptides for use in therapy
JPWO2022149609A1 (ja) * 2021-01-07 2022-07-14
CN113354716B (zh) * 2021-08-11 2021-11-02 北京溯本源和生物科技有限公司 一种鼠诺如病毒重组抗原、单克隆抗体和病毒检测试纸条

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2581394B1 (fr) 1985-05-02 1988-08-05 Grp Genie Genetique Particules ayant les proprietes immunogenes de l'antigene hbs et portant un site antigenique etranger aux epitopes portes par l'antigene hbs, vecteurs et cellules animales pour la production de telles particules et compositions contenant de telles particules pour la production de vaccins mixtes
ATE415173T1 (de) 1993-09-14 2008-12-15 Pharmexa Inc Pan dr-bindeproteinen zur erhöhung der immunantwort
JP4085231B2 (ja) 2000-02-28 2008-05-14 株式会社ビークル タンパク質中空ナノ粒子とそれを用いた物質運搬体、ならびに細胞への物質導入方法
JP4509999B2 (ja) 2003-02-17 2010-07-21 ブルクハルト,ペーター 医薬送達及び抗原提示システムとしてのペプチドナノ粒子
CN104740624B (zh) * 2007-09-18 2018-04-24 武田疫苗股份有限公司 赋予针对诺如病毒的保护性免疫应答的疫苗
WO2009109428A2 (en) 2008-02-01 2009-09-11 Alpha-O Peptides Ag Self-assembling peptide nanoparticles useful as vaccines
DE602008004898D1 (de) * 2008-06-27 2011-03-24 Theranor Sprl Pharmazeutische Zusammensetzungen von Antikörpern von Viruserkrankungen

Also Published As

Publication number Publication date
US20140242104A1 (en) 2014-08-28
WO2013053642A1 (en) 2013-04-18
EP2766386A1 (en) 2014-08-20
AU2012323189A1 (en) 2014-03-06
RU2014106936A (ru) 2015-11-20
JP2014530224A (ja) 2014-11-17
CA2851917A1 (en) 2013-04-18
CN104136454A (zh) 2014-11-05

Similar Documents

Publication Publication Date Title
IN2014CN03364A (ja)
CY1122278T1 (el) Αντι il-36r αντισωματα
CY1121392T1 (el) Μορια δεσμευσης εναντι-αλφα συνουκλεϊνης
CY1120398T1 (el) Ανθρωποποιημενα αντισωματα που αναγνωριζουν αλφα-συνουκλεϊνη
DK2728002T3 (da) Heterodimeriseret polypeptid
CY1118906T1 (el) Χαμηλης συγγενειας αντισωματα υποδοχεα αιματοεγκεφαλικου φραγμου και χρησεις αυτων
MX2015006548A (es) Proteinas vinculantes que comprenden al menos dos dominios de repeticion contra her2.
CY1119567T1 (el) Θεραπευτικα πεπτιδια
DK2940135T5 (da) Heterodimeriseret polypeptid
HK1224178A1 (zh) 環肽作為蛋白質靶向劑
CY1116842T1 (el) Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου
WO2012031250A3 (en) Compositions for labeling nerves and methods of use
DK2797616T3 (da) Celle-penetrerende peptider
BR112014017749A2 (pt) Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo
WO2009109428A3 (en) Self-assembling peptide nanoparticles useful as vaccines
EP3082797A4 (en) Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
CY1118885T1 (el) Συνθετικες πεπτιδογλυκανες που δεσμευουν υαλουρονικο οξυ, παρασκευη, και μεθοδοι χρησης
MX355268B (es) Anticuerpos de peptido beta amiloide anti-n3pglu y usos de los mismos.
UY34608A (es) Péptidos sintéticos de tránsito al cloroplasto.
JP2014518898A5 (ja)
EA201390074A1 (ru) 5-хлор-4-гидрокси-1-метил-2-оксо-n-фенил-1,2-дигидрохинолин-3-карбоксамид, его соли и применения
EA201490778A1 (ru) АНТИТЕЛА ПРОТИВ HtrA1 И СПОСОБЫ ПРИМЕНЕНИЯ
UA118167C2 (uk) Пептид та його застосування
BR112013030824A2 (pt) bactéria gram-positiva, ácido necleico recombinante, composição farmacêutica e vetor
UA106900C2 (uk) Агоністичний dr5-зв'язувальний поліпептид